T. Rowe Price Associates’s Covisint Corporation COVS Stock Holding History

T. Rowe Price Associates’s Portfolio COVS Stock Details COVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q3	–	Sell	-47,257	Closed	-$116K	–	2624
2017 Q2	$116K	Sell	47,257 -1,400	-3%	-$2.92K	﹤0.01%	2467
2017 Q1	$100K	Sell	48,657 -9,300	-16%	-$18.6K	﹤0.01%	2489
2016 Q4	$110K	Sell	57,957 -1,900	-3%	-$4.1K	﹤0.01%	2462
2016 Q3	$130K	Sell	59,857 -8,504	-12%	-$18.6K	﹤0.01%	2411
2016 Q2	$149K	Buy	68,361 +11,300	+20%	+$21.9K	﹤0.01%	2375
2016 Q1	$114K	Buy	57,061 +10,500	+23%	+$21.3K	﹤0.01%	2399
2015 Q4	$116K	Buy	46,561 +7,000	+18%	+$15.8K	﹤0.01%	2401
2015 Q3	$85K	Sell	39,561 -600	-1%	-$1.65K	﹤0.01%	2426
2015 Q2	$131K	Sell	40,161 -58,800	-59%	-$139K	﹤0.01%	2427
2015 Q1	$201K	Buy	98,961 +59,400	+150%	+$139K	﹤0.01%	2350
2014 Q4	$105K	Buy	+39,561	New	+$113K	﹤0.01%	2465

T. Rowe Price Associates's COVS Position: Q3 2017 in Review

T. Rowe Price Associates sold out of Covisint Corporation (COVS) in Q3 2017, closing a stake of 47,257 shares — an estimated $116K sold.

T. Rowe Price Associates first reported a position in COVS in Q4 2014 and held it in 11 quarters. The position peaked at $201K in Q1 2015. 0 funds tracked by Wall St. Rank hold COVS as of Q3 2017.

T. Rowe Price Associates reported no remaining Covisint Corporation position as of Q3 2017 after selling out during the quarter.
T. Rowe Price Associates sold 47,257 Covisint Corporation shares in Q3 2017, an estimated $116K.
T. Rowe Price Associates first reported a position in Covisint Corporation in Q4 2014 and held it in 11 quarters.
T. Rowe Price Associates's Covisint Corporation position peaked at $201K in Q1 2015.
0 funds tracked by Wall St. Rank held Covisint Corporation as of Q3 2017.

Based on T. Rowe Price Associates's 13F filing for Q3 2017, filed 14 Nov 2017.